In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium

D.J.A. Lobbezoo, R.J.W. van Kampen, A. C. Voogd, M. W. Dercksen, F. van den Berkmortel, T. J. Smilde, A. J. van de Wouw, F. P. J. Peters, J. M. G. H. van Riel, N. A. J. B. Peters, M. de Boer, P. G. M. Peer, V. C. G. Tjan-Heijnen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

50 Citations (Web of Science)
Original languageEnglish
Pages (from-to)256-262
Number of pages7
JournalAnnals of Oncology
Issue number2
Publication statusPublished - Feb 2016


  • metastatic breast cancer
  • chemotherapy
  • endocrine therapy
  • outcome
  • hormone receptor

Cite this